Drug Type Small molecule drug |
Synonyms Pyridorin, Pyridoxamine dihydrochloride, Pyridoxamine hydrochloride + [7] |
Mechanism Advanced glycation end product inhibitors |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC8H12N2O2 |
InChIKeyNHZMQXZHNVQTQA-UHFFFAOYSA-N |
CAS Registry85-87-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00082 | Pyridoxamine | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic Nephropathies | Phase 2 | - | - | |
Diabetic Nephropathies | Phase 2 | HK | - | |
Menopausal syndrome | Phase 2 | JP | - | |
Premenstrual Dysphoric Disorder | Phase 2 | JP | - | |
Premenstrual Syndrome | Phase 2 | JP | - | |
Diabetic Nephropathies | Preclinical | - | - | |
Diabetic Nephropathies | Preclinical | - | - | |
Diabetes Mellitus, Insulin-Dependent, 2 | Discovery | - | 01 Oct 2001 | |
Diabetic Nephropathies | Discovery | - | - | |
Diabetic Nephropathies | Discovery | HK | - |
Not Applicable | 10 | ryebubnzgq(zztkveoamj) = Wernicke's encephalopathy-like adverse drug reactions occurred in two patients followed with completely recovery by thiamine supplementation mbwrxzeeyx (kjghguvztt ) View more | Positive | 13 Nov 2016 |